Codexis, Inc. (LON:0I0X)

Market Cap	168.24M
Revenue (ttm)	38.56M
Net Income (ttm)	-57.63M
Shares Out	n/a
EPS (ttm)	-0.75
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,288
Average Volume	6,610
Open	2.700
Previous Close	2.880
Day's Range	2.681 - 2.780
52-Week Range	1.920 - 6.051
Beta	2.52
RSI	44.48
Earnings Date	Aug 7, 2025

About Codexis

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorp...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 188
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I0X

Financial Performance

In 2024, Codexis's revenue was $59.35 million, a decrease of -15.39% compared to the previous year's $70.14 million. Losses were -$65.28 million, -14.38% less than in 2023.

Financial numbers in USD